SGX Pharmaceuticals Announces Fourth Quarter and Full Year Financi...(640 $8642 $7143 $2445 $9588 ....),Health

SGX PHARMACEUTICALS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

(unaudited)

December 31, December 31,

2007 2006

Assets

Cash, cash equivalents and short-

term investments $38,990 $33,877

Accounts receivable 2,706 3,532

Other current assets 1,187 1,616

Property and equipment, net 3,889 5,435

Other assets 4,284 4,004

Total assets $51,056 $48,464

Liabilities and stockholder's equity

Current liabilities $24,991 $21,762

Deferred revenue, long-term 1,042 13,023

Other liabilities, net of current

portion - 66

Stockholder's equity 25,023 13,613

Total liabilities and

stockholder's equity $51,056 $48,464

1) In addition to disclosing financial results calculated in accordance with generally accepted accounting principles (GAAP), this table contains non-GAAP financial measures that exclude the effect of non-cash stock compensation expense. The Company believes that the presentation of results excluding non-cash stock compensation expense provides meaningful supplemental information to both management and investors that is indicative of the Company's core operating results. The Company believes these non-GAAP
'/>"/>